{"id":2569,"date":"2020-11-18T17:25:12","date_gmt":"2020-11-18T17:25:12","guid":{"rendered":"https:\/\/peninsula360press.com\/?p=2569"},"modified":"2021-10-11T08:40:15","modified_gmt":"2021-10-11T15:40:15","slug":"covid-19-vaccine-from-pfizer-would-be-approved-for-emergency-use-now-it-is-95-effective","status":"publish","type":"post","link":"https:\/\/peninsula360press.com\/en\/covid-19-vaccine-from-pfizer-would-be-approved-for-emergency-use-now-it-is-95-effective\/","title":{"rendered":"COVID-19: Pfizer vaccine would be approved for emergency use, now 95% effective"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n
Christian Carlos<\/a>. Peninsula 360 Press [P360P].<\/h5>\n\n\n\n

After two months of collecting samples and showing results, pharmacist Pfizer increased the effectiveness of its vaccine against SARS-CoV-2, the new coronavirus that causes COVID-19 disease, from 90 percent to 95 percent. According to data from statistics recently collected by NBC, this has left more than 250 unfortunate deaths in the United States.<\/p>\n\n\n\n

On Monday, Nov. 9, it was announced that Pfizer's vaccine, in conjunction with the German firm BioNTech, was only 90 percent effective; however, both companies warned that, once the required studies were completed, there was a high probability that its final efficacy would be different.<\/p>\n\n\n\n

The Food and Drug Administration (FDA) would give emergency approval for its use in the next few days; if so, it would be the first vaccine on the market to combat the COVID-19 pandemic. Pfizer's vaccine is in phase 3 of its clinical trials.<\/p>\n\n\n\n

To reach 95 percent effectiveness, more than 43,000 volunteers were required, the pharmacist conducted tests where the FDA imposed a limit of up to 170 COVID-19 infections; of these, 162 corresponded to a placebo dose and only in eight people was the vaccine not effective.<\/p>\n\n\n\n

It should be noted that the vaccine is up to 94 percent effective in people over 65. Regarding the side effects of the vaccine, Pfizer says: \"The data show that the vaccine was well tolerated (?) no serious safety problems were observed; the only adverse event of third degree, with a frequency higher than 2%, were cases of fatigue in 3.8% and headache in 2.0%\".<\/p>\n\n\n\n

In the statement<\/a> explains that: \"The primary efficacy analysis shows that BNT162b2 - the vaccine batch - has an efficacy of 95% against COVID-19 starting 28 days after the first dose; 170 confirmed cases of COVID-19 were evaluated, with 162 volunteers in the placebo group versus 8 in the vaccine group\".<\/p>\n\n\n\n

It should be noted that just this Monday, it was announced that the vaccine developed by Moderna reached an effectiveness of 94.5%; however, compared to the vaccine developed by Pfizer, it showed the same effectiveness in cases where patients had already been infected with the SARS-CoV-2 virus.<\/p>\n\n\n\n

However, Moderna has to go through FDA approval after two months of successful testing for emergency introduction, a process that Pfizer has completed.<\/p>\n\n\n\n

Finally, Pfizer expects its formula to be replicated internationally, stating that: \"they expect to produce up to 50 million doses of vaccine globally by 2020 and up to 1.3 billion doses by the end of 2021.<\/p>","protected":false},"excerpt":{"rendered":"

Cristian Carlos. Pen\u00ednsula 360 Press [P360P]. Luego de dos meses de recopilaci\u00f3n de muestras y muestro de resultados, la farmac\u00e9utica Pfizer elev\u00f3 de 90 por ciento a 95 por ciento la eficacia de su vacuna contra el SARS-CoV-2, el nuevo coronavirus que causa la enfermedad COVID-19 que, de acuerdo con datos de estad\u00edsticos reci\u00e9n recopilados […]<\/p>","protected":false},"author":4,"featured_media":2570,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,8,12],"tags":[273],"class_list":{"0":"post-2569","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cover","8":"category-usworld","9":"category-health","10":"tag-ccj"},"_links":{"self":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts\/2569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/comments?post=2569"}],"version-history":[{"count":3,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts\/2569\/revisions"}],"predecessor-version":[{"id":7582,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts\/2569\/revisions\/7582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/media\/2570"}],"wp:attachment":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/media?parent=2569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/categories?post=2569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/tags?post=2569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}